wada aod9604 prohibited list 2025 Reminder: WADA's comes into force on 1 January World Anti-Doping Agency (WADA) Prohibited

For researchers whose metabolic study programme also involves growth factor signalling alongside lipolysis research, our IGF-1 LR3 1mg research guide covers the growth factor peptide most commonly used as a mechanistic counterpart to AOD-9604, operating through the IGF-1 receptor pathway rather than the beta-3 adrenergic system, providing a complementary non-overlapping molecular probe for multi-pathway metabolic studies

For a broader view of peptide-based fat loss options beyond the GLP-1 class, the peptides for fat loss page covers the full range of available and emerging compounds

These injections prevent the accumulation of fats in the liver and increase your daily energy level

In addition to these benefits, Lipo-B12 injections also work well for those who want to balance their hormones and improve liver function while trying to lose weight